Skip to content

JROAD data-based nationwide research for the prognostic factors of Cardiac Resynchronization Therapy Study (JPN-CRT study)

JROAD data-based nationwide research for the prognostic factors of Cardiac Resynchronization Therapy Study (JPN-CRT study) - JPN-CRT study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000052273
Enrollment
8000
Registered
2023-10-01
Start date
2023-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic heart failure, patients with cardiac resynchronization therapy devices

Interventions

None listed

Sponsors

National Cerebral and Cardiovascular Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients implanted with cardiac resynchronization therapy with a defibrillator or cardiac resynchronization therapy pacemaker from April 1, 2016, to March 31, 2021.

Exclusion criteria

Exclusion criteria: 1. Cases without a sufficient data for analysis 2. Patients who requested not to participate in the study

Design outcomes

Primary

MeasureTime frame
Composite outcomes of all-cause death, heart transplantation, and heart failure hospitalization

Countries

Japan

Contacts

Public ContactNobuhiko Ueda

National Cerebral and Cardiovascular Center Cardiovascular department, division of arrhythmia

crt_jimukyoku@ncvc.go.jp06-6170-1069

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026